X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P86
Within normal range
vs 2Y Ago
1.9x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.85% |
| Q3 2025 | -4.87% |
| Q2 2025 | -177.79% |
| Q1 2025 | 73.56% |
| Q4 2024 | -3.52% |
| Q3 2024 | -148.52% |
| Q2 2024 | 290.68% |
| Q1 2024 | -47.98% |
| Q4 2023 | 7.40% |
| Q3 2023 | -5.46% |
| Q2 2023 | 11.94% |
| Q1 2023 | -14.57% |
| Q4 2022 | -26.91% |
| Q3 2022 | 2.02% |
| Q2 2022 | 3.28% |
| Q1 2022 | 26.80% |
| Q4 2021 | -51.97% |
| Q3 2021 | -0.64% |
| Q2 2021 | -5.92% |
| Q1 2021 | -1.59% |
| Q4 2020 | -3.98% |
| Q3 2020 | -15.84% |
| Q2 2020 | -38.53% |
| Q1 2020 | 2.70% |
| Q4 2019 | 35.94% |
| Q3 2019 | -26.55% |
| Q2 2019 | -28.51% |
| Q1 2019 | -10.20% |
| Q4 2018 | 26.27% |
| Q3 2018 | -1.83% |
| Q2 2018 | -15.21% |
| Q1 2018 | 5.65% |
| Q4 2017 | 11.11% |
| Q3 2017 | -131.33% |
| Q2 2017 | 3.14% |
| Q1 2017 | -2.23% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |